OPEN TRIAL OF VALPROATE IN THE TREATMENT OF ADOLESCENT MANIA

被引：41

作者：

WEST, SA

KECK, PE

MCELROY, SL

STRAKOWSKI, SM

MINNERY, KL

MCCONVILLE, BJ

SORTER, MT

机构：

[1] Biological Psychiatry Program, Department of Psychiatry, Cincinnati, OH

[2] Division of Child and Adolescent Psychiatry, Dept. of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, OH

来源：

JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY | 1994年 / 4卷 / 04期

关键词：

D O I：

10.1089/cap.1994.4.263

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

Eleven adolescent patients with bipolar disorder (ages 12 to 17 years) hospitalized for acute mania were treated prospectively with open-label valproate after failing to respond to lithium and/or antipsychotics. Valproate doses ranged from 500 to 2000 mg/day, serum concentrations ranged from 38 to 94 mug/ml, and durations of inpatient valproate treatment ranged from six to 26 days. All 11 patients received concurrent antipsychotic medication, and five patients received concomitant lithium. Nine of the 11 patients had at least a moderate therapeutic response when valproate was added to their medication regimen. The only side effect was sedation, occurring in two patients. These preliminary data suggest that valproate may be an effective and well-tolerated treatment for acute mania in adolescents with bipolar disorder. Although valproate appears to have a generally favorable record of safety based on its long-term use in treating children and adolescents with seizure disorders, clinicians are advised to exercise caution until double-blind, placebo-controlled studies demonstrate safety and efficacy in adolescents with mania.

引用

页码：263 / 267

页数：5

共 16 条

[1]

Bowden C.L., Brugger A.M., Swann A.C., Calabrese J.R., Janicak P.G., Petty F., Dilsaver S.C., Davis J.M., Rush A.J., Small J.G., Garza-Trevino E.S., Risch S.C., Goodnick P.J., Morris D.D., Efficacy of divalproex versus lithium and placebo in the treatment of mania, JAMA, 271, pp. 918-924, (1994)

[2]

DeLong G.R., Aldershof A.L., Long-term experience with lithium treatment in children: Correlation with clinical diagnosis, J Am Acad Child Adolesc Psychiatry, 26, pp. 389-394, (1987)

[3]

Freeman T.W., Clothier J.L., Pazzaglia P., Lesern M.D., Swann A.C., A double-blind comparison of valproate and lithium in the treatment of acute mania, Am J Psychiatry, 149, pp. 108-111, (1992)

[4]

Goodwin F.K., Jamison K.R., Manic-Depressive Illness, pp. 128-132, (1990)

[5]

Hamilton M., The assessment of anxiety states by rating, Br J Med Psychol, 32, pp. 50-55, (1959)

[6]

Hamilton M., A rating scale for depression, J Neurol Neurosurg Psychiatry, 23, pp. 56-62, (1960)

[7]

Kastner T., Friedman D.L., Plummer A.T., Ruiz M.Q., Henning D., Valproic acid for the treatment of children with mental retardation and mood symptomatology, Pediatrics, 86, pp. 467-472, (1990)

[8]

McElroy S.L., Keck P.E., Pope H.G., Hudson J.I., Valproate in the treatment of bipolar disorder: Literature review and clinical guidelines, J Clin Psychopharmacol, 12, pp. 42S-52S, (1992)

[9]

Orvaschel H., Puig-Antich G., The Kiddie-SADS-III-R, (1987)

[10]

Papatheodorou G., Kutcher S.P., Divalproex sodium treatment in late adolescent and young adult acute mania, Psychopharmacol Bull, 29, pp. 213-219, (1993)

← 1 2 →